{"transactions":[{"id":4637628,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-10-08T01:00:11.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted this option pursuant to the 2026 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2027 annual meeting of stockholders or October 5, 2027."}],"balance_after":64000,"derivative":{"exercise_price":3.75,"expiration_date":"2036-10-05","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001193125-26-417236","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821285/000119312526417236/ownership.xml","form_type":"4"}},{"id":4637627,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-08T01:00:11.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":10700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted this restricted stock unit award (RSU) pursuant to the 2026 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2027 annual meeting of stockholders or October 5, 2027."}],"balance_after":35668,"source":{"system":"sec-edgar","filing":"0001193125-26-417236","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821285/000119312526417236/ownership.xml","form_type":"4"}},{"id":687689,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-14T01:00:05.000Z","date":"2026-08-11","kind":"sale","planned":true,"acquired":false,"shares":432,"price":6.01,"value":2596.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 11, 2026, the reporting person sold 432 shares of common stock solely to cover taxes associated with the vesting of restricted stock units on August 11, 2026. These sales were made pursuant to a previously adopted 10b5-1 Trading Plan."}],"balance_after":24968,"source":{"system":"sec-edgar","filing":"0001193125-26-349960","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312526349960/ownership.xml","form_type":"4"}},{"id":973997,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-11T02:45:11.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":false,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These share options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.97,"expiration_date":"2026-08-16","underlying":"Ordinary Shares","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001193125-25-314739","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314739/ownership.xml","form_type":"4"}},{"id":973996,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-11T02:45:11.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":false,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These share options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.5,"expiration_date":"2027-08-15","underlying":"Ordinary Shares","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001193125-25-314739","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314739/ownership.xml","form_type":"4"}},{"id":973995,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-11T02:45:11.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These share options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.585,"expiration_date":"2028-08-07","underlying":"Ordinary Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001193125-25-314739","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314739/ownership.xml","form_type":"4"}},{"id":973994,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-11T02:45:11.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":false,"shares":32230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These share options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.37,"expiration_date":"2029-08-12","underlying":"Ordinary Shares","underlying_shares":32230},"source":{"system":"sec-edgar","filing":"0001193125-25-314739","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314739/ownership.xml","form_type":"4"}},{"id":973993,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:11.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":21000,"price":12.75,"value":267750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."}],"balance_after":25400,"source":{"system":"sec-edgar","filing":"0001193125-25-314739","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314739/ownership.xml","form_type":"4"}},{"id":973992,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:11.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":true,"shares":21000,"price":5.97,"value":125370.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."}],"balance_after":46400,"source":{"system":"sec-edgar","filing":"0001193125-25-314739","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314739/ownership.xml","form_type":"4"}},{"id":973991,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:11.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":21000,"price":12.75,"value":267750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."}],"balance_after":25400,"source":{"system":"sec-edgar","filing":"0001193125-25-314739","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314739/ownership.xml","form_type":"4"}},{"id":973990,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:11.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":true,"shares":21000,"price":3.5,"value":73500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."}],"balance_after":46400,"source":{"system":"sec-edgar","filing":"0001193125-25-314739","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314739/ownership.xml","form_type":"4"}},{"id":973989,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:11.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":15,"value":375000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."}],"balance_after":25400,"source":{"system":"sec-edgar","filing":"0001193125-25-314739","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314739/ownership.xml","form_type":"4"}},{"id":973988,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:11.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":12.75,"value":255000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."}],"balance_after":50400,"source":{"system":"sec-edgar","filing":"0001193125-25-314739","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314739/ownership.xml","form_type":"4"}},{"id":973987,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:11.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":true,"shares":45000,"price":4.585,"value":206325.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."}],"balance_after":70400,"source":{"system":"sec-edgar","filing":"0001193125-25-314739","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314739/ownership.xml","form_type":"4"}},{"id":973986,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:11.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":17230,"price":15,"value":258450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."}],"balance_after":25400,"source":{"system":"sec-edgar","filing":"0001193125-25-314739","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314739/ownership.xml","form_type":"4"}},{"id":973985,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:11.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":12.75,"value":191250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."}],"balance_after":42630,"source":{"system":"sec-edgar","filing":"0001193125-25-314739","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314739/ownership.xml","form_type":"4"}},{"id":973984,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:11.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":true,"shares":32230,"price":5.37,"value":173075.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."}],"balance_after":57630,"source":{"system":"sec-edgar","filing":"0001193125-25-314739","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314739/ownership.xml","form_type":"4"}},{"id":973983,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:11.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":7494,"price":15,"value":112410.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."}],"balance_after":25400,"source":{"system":"sec-edgar","filing":"0001193125-25-314739","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314739/ownership.xml","form_type":"4"}},{"id":973982,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:11.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":7494,"price":12.75,"value":95548.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."}],"balance_after":32894,"source":{"system":"sec-edgar","filing":"0001193125-25-314739","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314739/ownership.xml","form_type":"4"}},{"id":1061192,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-08-20T00:00:04.000Z","date":"2025-08-15","kind":"exercise","planned":true,"acquired":false,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These share options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":9.13,"expiration_date":"2025-08-18","underlying":"Ordinary Shares","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000950170-25-110287","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017025110287/ownership.xml","form_type":"4"}},{"id":1061191,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-20T00:00:04.000Z","date":"2025-08-15","kind":"sale","planned":true,"acquired":false,"shares":21000,"price":9.25,"value":194250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."}],"balance_after":40388,"source":{"system":"sec-edgar","filing":"0000950170-25-110287","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017025110287/ownership.xml","form_type":"4"}},{"id":1061190,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-20T00:00:04.000Z","date":"2025-08-15","kind":"exercise","planned":true,"acquired":true,"shares":21000,"price":9.13,"value":191730.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."}],"balance_after":61388,"source":{"system":"sec-edgar","filing":"0000950170-25-110287","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017025110287/ownership.xml","form_type":"4"}},{"id":1067510,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-08-14T00:00:12.000Z","date":"2025-08-11","kind":"grant","planned":false,"acquired":true,"shares":152400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted this option pursuant to the 2025 Non-Employee Director Compensation Policy. The option vests as to 12.5% on a quarterly basis beginning August 11, 2025, through the two-year period following the grant date."}],"balance_after":152400,"derivative":{"exercise_price":8.105,"expiration_date":"2030-08-11","underlying":"Ordinary Shares","underlying_shares":152400},"source":{"system":"sec-edgar","filing":"0000950170-25-108290","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017025108290/ownership.xml","form_type":"4"}},{"id":1067509,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-14T00:00:12.000Z","date":"2025-08-11","kind":"grant","planned":false,"acquired":true,"shares":25400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted this restricted share unit award (RSU) pursuant to the 2025 Non-Employee Director Compensation Policy. The RSU vests as to 50% on each of (i) the earlier of the Company's 2026 annual general meeting or August 11, 2026; and (ii) the earlier of the Company's 2027 annual general meeting or August 11, 2027."}],"balance_after":40388,"source":{"system":"sec-edgar","filing":"0000950170-25-108290","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017025108290/ownership.xml","form_type":"4"}},{"id":1071985,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-08T00:00:04.000Z","date":"2025-08-05","kind":"sale","planned":true,"acquired":false,"shares":1127,"price":8.75,"value":9861.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 5, 2025, the reporting person sold 1,127 ordinary shares solely to cover taxes associated with the vesting of restricted share units on August 5, 2025.These sales were made pursuant to a 10b5-1 Trading Plan."}],"balance_after":14988,"source":{"system":"sec-edgar","filing":"0000950170-25-105352","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017025105352/ownership.xml","form_type":"4"}},{"id":1433332,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2024-08-14T22:00:09.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":32230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted this option pursuant to the 2024 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2025 annual general meeting or August 12, 2025."}],"balance_after":32230,"derivative":{"exercise_price":5.37,"expiration_date":"2029-08-12","underlying":"Ordinary Shares","underlying_shares":32230},"source":{"system":"sec-edgar","filing":"0000950170-24-097289","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017024097289/ownership.xml","form_type":"4"}},{"id":1433331,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-08-14T22:00:09.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":16115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted this restricted share unit award (RSU) pursuant to the 2024 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2025 annual general meeting or August 12, 2025."}],"balance_after":16115,"source":{"system":"sec-edgar","filing":"0000950170-24-097289","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017024097289/ownership.xml","form_type":"4"}},{"id":1811686,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2023-08-10T00:00:33.000Z","date":"2023-08-07","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2024 annual general meeting or August 7, 2024."}],"balance_after":45000,"derivative":{"exercise_price":4.58,"expiration_date":"2028-08-07","underlying":"Ordinary Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-23-017916","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924323017916/doc4.xml","form_type":"4"}},{"id":2180636,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2022-08-18T00:00:17.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2023 annual general meeting or August 15, 2023."}],"balance_after":21000,"derivative":{"exercise_price":3.5,"expiration_date":"2027-08-15","underlying":"Ordinary Shares","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000899243-22-029094","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924322029094/doc4.xml","form_type":"4"}},{"id":2597191,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2021-08-18T22:07:51.000Z","date":"2021-08-16","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2022 annual general meeting or August 16, 2022."}],"balance_after":21000,"derivative":{"exercise_price":5.97,"expiration_date":"2026-08-16","underlying":"Ordinary Shares","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000899243-21-033519","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924321033519/doc4.xml","form_type":"4"}},{"id":3050658,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23619,"kind":"person","name":"Tan Aik Na","position":1,"cik":"0001821285","reported_name":"Tan Aik Na","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2020-08-20T22:30:05.000Z","date":"2020-08-18","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 25% of the shares on August 18, 2021 and the remainder vests quarterly thereafter until August 18, 2024."}],"balance_after":21000,"derivative":{"exercise_price":9.13,"expiration_date":"2025-08-18","underlying":"Ordinary Shares","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000899243-20-023080","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924320023080/doc4.xml","form_type":"4"}}]}